Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Memphis Pharmaceutical and Chemical Industries is a leading Egyptian pharmaceutical manufacturer founded in 1940, making it one of the oldest companies in the region's healthcare sector. As a subsidiary of the state-owned Holding Company for Pharmaceuticals, Chemicals and Medical Appliances (HoldiPharma), it specializes in the development and production of a wide range of generic medicines, veterinary products, and cosmetics. The company operates a diversified manufacturing portfolio including oral solids, syrups, injectables, and ointments across various therapeutic areas such as cardiovascular, respiratory, and gastrointestinal health. Memphis Pharma is also a significant player in contract manufacturing, partnering with international pharmaceutical firms to produce licensed medications for the Egyptian and regional markets. It is publicly listed on the Egyptian Exchange and maintains certifications for Good Manufacturing Practices (GMP).
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Memphis Pharmaceutical and Chemical Industries.